AFC
RMD icon

Ares Financial Consulting’s ResMed RMD Stock Holding History

Ares Financial Consulting’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.82K Hold
35
– – ﹤0.01% 647
2026
Q1 		$7.8K Hold
35
– – 0.01% 600
2025
Q4 		$8.43K Buy
+35
New +$8.95K 0.01% 383

Other funds holding RMD

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TIA
Tandem Investment Advisors Charleston, South Carolina $1.49B AUM 12.33% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Ares Financial Consulting's RMD Position: Q2 2026 in Review

Ares Financial Consulting held its ResMed (RMD) position steady in Q2 2026 at 35 shares worth $6.82K. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Ares Financial Consulting first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.43K in Q4 2025. 410 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Ares Financial Consulting held 35 shares of ResMed worth $6.82K as of Q2 2026.
  • Ares Financial Consulting left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #647 holding.
  • Ares Financial Consulting first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
  • Ares Financial Consulting's ResMed position peaked at $8.43K in Q4 2025.
  • 410 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.